Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1983-4-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
308
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
654-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6298624-Adrenal Gland Neoplasms,
pubmed-meshheading:6298624-Adult,
pubmed-meshheading:6298624-Catecholamines,
pubmed-meshheading:6298624-Humans,
pubmed-meshheading:6298624-Male,
pubmed-meshheading:6298624-Naloxone,
pubmed-meshheading:6298624-Pheochromocytoma,
pubmed-meshheading:6298624-Receptors, Opioid
|
pubmed:year |
1983
|
pubmed:articleTitle |
Naloxone administration releases catecholamines.
|
pubmed:publicationType |
Letter,
Case Reports
|